Pan-cancer analysis identifies YTHDF2 as an immunotherapeutic and prognostic biomarker

Pan-cancer analysis identifies YTHDF2 as an immunotherapeutic and prognostic biomarker

Background: N6-methyladenosine (m6A) modification is a dynamic and reversible post-transcriptional RNA modification prevalent in eukaryotic cells. YT521-B homology domain family 2 (YTHDF2) has been identified as a member of m6A reader protein involving in many vital biological processes, whereas its...

Full description

Bibliographic Details
Main Authors: Weiwei Liu, Chaoqun Liu, Jia You, Zilin Chen, Cheng Qian, Wandie Lin, Lina Yu, Lele Ye, Liang Zhao, Rui Zhou
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
YTHDF2
prognosis
immunotherapy
immune cell infiltration
tumor microenvironment
Online Access:https://www.frontiersin.org/articles/10.3389/fcell.2022.954214/full

Internet

https://www.frontiersin.org/articles/10.3389/fcell.2022.954214/full

Similar Items